+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-08-02Number of Pages: 93

Cardiovascular Monitoring and Diagnostic Devices Market (Product - ECG Systems (Resting ECG, Stress ECG), Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Being the leading cause of death and witnessing a high rise in prevalence, the class of ailments that come under the purview of cardiovascular diseases is witnessing increased focus from healthcare, research, and government bodies alike. A large number of companies are venturing into the market with an innovative range of products for diagnosing and treating a variety of cardiovascular diseases. Research and development activities are being granted increasingly more funds and governments bodies are implementing various health schemes aimed at reducing the prevalence and improving awareness about cardiovascular diseases.

Transparency Market Research states that the global cardiovascular monitoring and diagnostic devices market held an opportunity of US$1.8 bn in 2015. The market is expected to expand at a 6.4% CAGR over the period between 2016 and 2024, and rise to a valuation of US$3.1 bn by 2024.

Electrocardiogram (ECG) Systems Lead on Account of Cost Effectiveness and High Efficiency

The product segment of ECG systems presently holds the largest share in the global cardiovascular monitoring and diagnostic devices market. The widespread presence and high preference for ECG systems in developed and developing regions alike are key to the segment’s leading market position. ECG systems are expected to remain the key contributor to the market’s overall revenues over 206 and 2024 as well, expanding at a 6.3% CAGR in the global market.

However, the segment of implantable loop recorders is expected to witness the fastest expansion, a 7.1% CAGR from 2016 to 2024. The segment is projected to benefit from the rising awareness about the use of these devices in diagnosing syncope. As several cases of the disease remain undiagnosed when other conventional diagnostic methods are used, implantable loop recorders are gaining an increased level of adoption across medical diagnostic centers globally. The valuation of the segment is expected to reach US$152.7 mn by 2024.

The segment of Holter monitors also holds immense growth promise owing to the rising prevalence of conditions such as arrhythmia and conduction block. The segment was valued at US$416.1 mn in 2015 and is expected to expand at a high single-digit CAGR from 2016 to 2024.

cardiovascular-monitoring-diagnostic-devices-market

 

North America to Continue Taking Largest Share of Pie but Emerging Economies Hold More Promise

North America accounted for the largest share of the overall revenues of the global cardiovascular monitoring and diagnostic devices market in 2015. The region is expected to remain the largest market over the period between 2016 and 2024 as well. Factors such as favorable reimbursement policies, high awareness about available diagnosis and treatment methods among patients and physicians, favorable reimbursement policies, and efficient healthcare infrastructure are factors that will help North America remain at the forefront of the global market. Europe, the second largest contributor to the global cardiovascular monitoring and diagnostic devices market in 2015, will also remain a lucrative owing to large scale healthcare infrastructure development activities and rising prevalence of cardiovascular disease.

However, developing regions such as Latin America and Asia Pacific will present the most promising growth opportunities for the global cardiovascular monitoring and diagnostic devices market over the period between 2016 and 2024. The presence of vast untapped growth prospects, rising healthcare expenditure, and increasing awareness about the efficiency of available techniques and devices in effectively curing several cardiovascular conditions will remain key to the overall growth of the market.

Several research studies also state that the risk of cardiovascular diseases is substantially high in mid- and low-income economies. This substantiates the fact that a large variety of cardiovascular monitoring and diagnostic devices will be consumed in Asia Pacific and Latin America in the next few years. The market for these devices will expand at a 7.5% in Asia Pacific and a 7.3% CAGR in Latin America over the period between 2016 and 2024.

In the highly dynamic global market for cardiovascular monitoring and diagnostic devices market, the top two vendors, GE Healthcare and Philips Healthcare accounted for a more than 55% of the global market in 2015. Other key vendors in the market are Spacelabs Healthcare, St. Jude Medical, Inc., and Siemens Healthcare.

1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography, 2013–2024 (US$ Mn)
     2.2. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Product Type, 2015 (US$ Mn)
     2.3. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Geography, 2015 and 2024 (Value %)
     2.4. Cardiovascular Monitoring and Diagnosis Devices: Market Snapshot

3. Industry Analysis: Cardiovascular Monitoring and Diagnosis Devices Market
     3.1. Industry Overview
     3.2. Market Drivers
     3.3. Market Restraints
     3.4. Market Opportunities
     3.5. Porter’s Five Forces Analysis
     3.6. Market Attractiveness 
     3.7. Market Positioning of Key Players, (Value %) (2015)
     3.8. Recommendations 
     3.9. Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Product Type, 2013-2024 (US$ Mn)
            3.9.1. Introduction
            3.9.2. ECG Systems
                     3.9.2.1. Resting ECG Systems
                     3.9.2.2. Stress ECG Systems
            3.9.3. Event Monitors
            3.9.4. Holter Monitors
            3.9.5. Implantable Loop Recorders
            3.9.6. ECG Management Systems

4. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography
     4.1. Introduction: Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.2. North America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.3. Europe Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.4. Asia Pacific Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.5. Latin America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)
     4.6. Rest of World Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013–2024 (US$ Mn)

5. Company Profiles
     5.1. Boston Scientific Corporation
            5.1.1. Company Overview
            5.1.2. Product Portfolio
            5.1.3. Financial Overview
            5.1.4. Product Portfolio
            5.1.5. Recent Developments
     5.2. Fukuda Denshi Co. Ltd.
            5.2.1. Company Overview
            5.2.2. Product Portfolio
            5.2.3. Financial Overview
            5.2.4. Product Portfolio
            5.2.5. Recent Developments
     5.3. GE Healthcare
            5.3.1. Company Overview
            5.3.2. Product Portfolio
            5.3.3. Financial Overview
            5.3.4. Product Portfolio
            5.3.5. Recent Developments
     5.4. Hill-Rom Holdings, Inc.
            5.4.1. Company Overview
            5.4.2. Product Portfolio
            5.4.3. Financial Overview
            5.4.4. Product Portfolio
            5.4.5. Recent Developments
     5.5. Johnson & Johnson
            5.5.1. Company Overview
            5.5.2. Product Portfolio
            5.5.3. Financial Overview
            5.5.4. Product Portfolio
            5.5.5. Recent Developments
     5.6. LivaNova PLC
            5.6.1. Company Overview
            5.6.2. Product Portfolio
            5.6.3. Financial Overview
            5.6.4. Product Portfolio
            5.6.5. Recent Developments
     5.7. Medtronic plc
            5.7.1. Company Overview
            5.7.2. Product Portfolio
            5.7.3. Financial Overview
            5.7.4. Product Portfolio
            5.7.5. Recent Developments
     5.8. Nihon Kohden Corporation
            5.8.1. Company Overview
            5.8.2. Product Portfolio
            5.8.3. Financial Overview
            5.8.4. Product Portfolio
            5.8.5. Recent Developments
     5.9. Philips Healthcare
            5.9.1. Company Overview
            5.9.2. Product Portfolio
            5.9.3. Financial Overview
            5.9.4. Product Portfolio Company Overview
            5.9.5. Product Portfolio
            5.9.6. Financial Overview
            5.9.7. Product Portfolio
            5.9.8. Recent Developments
            5.9.9. Recent Developments
     5.10. Siemens Healthcare
            5.10.1. Company Overview
            5.10.2. Product Portfolio
            5.10.3. Financial Overview
            5.10.4. Product Portfolio
            5.10.5. Recent Developments
     5.11. Spacelabs Healthcare (OSI Systems, Inc.)
            5.11.1. Company Overview
            5.11.2. Product Portfolio
            5.11.3. Financial Overview
            5.11.4. Product Portfolio
            5.11.5. Recent Developments
     5.12. St. Jude Medical, Inc.,
            5.12.1. Company Overview
            5.12.2. Product Portfolio
            5.12.3. Financial Overview
            5.12.4. Product Portfolio
            5.12.5. Recent Developments

List of Figures

FIG 1. Market Segmentation
FIG 2. Global Cardiovascular Monitoring and Diagnostic Devices Market, Estimates and Forecast, by Revenue, (US$ Mn), 2013–2024
FIG 3. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, (US$ Mn), 2015
FIG 4. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography, (Value %), 2015 and 2024
FIG 5. St. Jude Medical HeartMate 3 (Left Ventricular Assist System)
FIG 6. Global Population, by Age group (%) 2000
FIG 7. Global Population, by Age group (%) 2050
FIG 8. Porter’s Five Forces Analysis: Cardiovascular Monitoring and Diagnostic Devices Market
FIG 9. Market Attractiveness Analysis - Cardiovascular Monitoring and Diagnostic Devices Market
FIG 10. Market Share of Companies, Cardiovascular Monitoring and Diagnostic Devices (%) (2015)
FIG 11. Global Resting ECG Systems Market Revenue, (US$ Mn), 2013–2024
FIG 12. Global Stress ECG Systems Market Revenue, (US$ Mn), 2013–2024
FIG 13. Global Event Monitors Market Revenue, (US$ Mn), 2013–2024
FIG 14. Global Holter Monitors Market Revenue, (US$ Mn), 2013–2024
FIG 15. Global Implantable Loop Recorders Market Revenue, (US$ Mn), 2013–2024
FIG 16. Global ECG Management Systems Market Revenue, (US$ Mn), 2013–2024
FIG 17. Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, (US$ Mn), 2013–2024
FIG 18. Boston Scientific Corporation Financial Overview (US$ Mn), 2013–2015
FIG 19. Fukuda Denshi Co., Ltd. Financial Overview (US$ Mn), 2013–2015
FIG 20. GE Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 21. Hill-Rom Holdings, Inc. Financial Overview (US$ Mn), 2013–2015
FIG 22. Johnson & Johnson Financial Overview (US$ Mn), 2013–2015
FIG 23. Medtronic plc Financial Overview (US$ Mn), 2013–2015
FIG 24. Nihon Kohden Corporation Financial Overview (US$ Mn), 2013–2015
FIG 25. Philips Healthcare Financial Overview: (US$ Mn), 2013–2015
FIG 26. Siemens Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 27. Spacelabs Healthcare Financial Overview (US$ Mn), 2013–2015
FIG 28. St. Jude Medical, Inc. Financial Overview (US$ Mn), 2013–2015

List of Tables

TABLE 1: Cardiovascular Monitoring and Diagnostic Devices Market Snapshot
TABLE 2: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type, (US$ Mn), 2013–2024
TABLE 3: Global ECG Systems Market Revenue (US$ Mn), 2013–2024
TABLE 4: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography, (US$ Mn), 2013–2024
TABLE 5: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 6: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 7: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 8: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 9: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 10: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 11: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013–2024
TABLE 12: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024
TABLE 13: Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013–2024

Global Cardiovascular Monitoring and Diagnostic Devices Market: Overview  

The number of deaths due to cardiovascular diseases and their prevalence has been increasing speedily in the last couple of years, thus attracting the attention of government bodies, bio research firms, and healthcare institutions alike. Numerous companies are venturing into the global cardiovascular monitoring and diagnostic devices market with an innovative approach and a range of high-end products for the purpose of treating various cardiovascular ailments. Research and development projects are being taken up by several institutions and there has also been a considerable rise in terms of the funding provided by governments. Furthermore, government organizations are also implementing different health schemes in order to improve the awareness level regarding cardiovascular diseases and reducing their prevalence.

The report is an investigation in the growth of the global cardiovascular monitoring and diagnostic devices market over the last couple of years and in the coming years. The market research publication further reasons out the causes of the changes in the market across the globe. It does this so by presenting an evaluation of the dynamics and the trends prevalent from the last few years and the ones that are likely to retain an impact during the forecast period. The Porter’s five forces analysis is being taken into consideration for the analysts to provide a clear view of the vendor landscape to the readers. Mergers, agreements, acquisitions, and other partnerships have also been highlighted in the report. The study further delves into the working of the various leading companies along with the information on the products, strategies, and shares of the companies in question.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Trends and Prospects  

With the growing number of people crossing the age of 65, the prevalence of cardiovascular diseases is also magnifying. It has been expected that a huge rise in the geriatric population across the world will trigger the demand for effective and efficient cardiovascular monitoring and diagnostic devices. The impact on the adoption of different varieties of cardiovascular monitoring and diagnostic devices across regions such as the Middle East and Asia Pacific is expected to be humungous due to the flourishing medical tourism sector in the emerging economies of these regions. The growth of the market is expected to be further supplemented by the low cost of procedure and availability of affordable and reliable labor, especially in countries such as Indonesia, China, India, and Turkey. The threat of cardiovascular diseases is also rising due to the prevalence of factors such as growing consumption of alcohol and tobacco, high level of stress, unhealthy food habits, and lack of physical activities. This, in turn, is also warranting the demand for cardiovascular monitoring and diagnostic devices across the globe.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Regional Outlook  

North America is expected to emerge as the leading market in the global cardiovascular monitoring and diagnostic devices market owing the favorable reimbursement policies provided by the governments in the region, growing awareness among consumers regarding the availability of treatment and diagnosis methods, and advanced healthcare infrastructure. Europe is likely to closely follow North America due to high incidence of cardiovascular diseases.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Vendor Landscape

 Some of the leading vendors in the market are Siemens Healthcare, St. Jude Medical Inc., Spacelabs Healthcare, Philips Healthcare, and GE Healthcare.

For this study, the market is segmented as follows:

Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product

  • ECG Systems
    • Resting ECG
    • Stress ECG
  • Event Monitors
  • Holter Monitors
  • Implantable Loop Recorders
  • ECG Management Systems

Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of the World


 
 
Back To Top